4.5 Article

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Yi-Yu Chen et al.

Summary: This study finds that the amplification of the ENSA gene at the 1q21.3 region promotes the progression of triple-negative breast cancer (TNBC) by up-regulating cholesterol biosynthesis. It identifies ENSA as a regulator of cholesterol biosynthesis that activates the expression of the SREBP2 transcription factor. It also shows the efficacy of a STAT3 inhibitor in TNBC with high ENSA expression.

NATURE COMMUNICATIONS (2022)

Article Genetics & Heredity

Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants

Takae Brewer et al.

Summary: Findings from this study suggest that breast cancers arising from germline PTEN variants have distinct genomic characteristics compared to sporadic breast cancers, including distinct somatic mutational landscape, increased genomic instability, and higher frequency of somatic PTEN variants. These findings have important implications for the personalized management of PTEN-related breast cancers.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Medicine, Research & Experimental

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC

Wei Chong et al.

Summary: This study investigated the association between tumor genomic features and clinical benefit of ICI treatment, revealing that an age-related clock-like mutational signature is linked to worse prognosis and lower immune activity. The findings suggest opportunities to stratify patients into optimal immunotherapy plans based on genomic subtyping.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Cell Biology

Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential

Adviti Naik et al.

Summary: PRAME in breast cancer is associated with poorer prognosis, especially in immune-unfavourable tumors. PRAME overexpression in cancer cells inhibits T cell activation and cytolytic potential, and reduces the expression of immune checkpoints and their ligands.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Genetics & Heredity

The context-specific role of germline pathogenicity in tumorigenesis

Preethi Srinivasan et al.

Summary: The study identified pathogenic germline variants in cancer predisposition genes in 17,152 patients with cancer, revealing different mechanisms of tumorigenesis based on the penetrance and lineage of the gene variants.

NATURE GENETICS (2021)

Article Oncology

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers

Yiduo Liu et al.

Summary: This study identified potential biomarkers for TNBC through bioinformatics analysis. Four genes were identified as prognostic signatures in the disease-free interval, while five genes were associated with the progression-free interval. Time-dependent ROC analysis indicated that the multivariate Cox regression models based on these genes had great predictive performance. Additionally, FAM83B was found to significantly affect the prognosis of patients in different TNBC subtypes.

BMC CANCER (2021)

Article Oncology

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

Xin Yang et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

Review Oncology

Emerging role of PTEN loss in evasion of the immune response to tumours

Thiago Vidotto et al.

BRITISH JOURNAL OF CANCER (2020)

Article Medicine, General & Internal

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition

Yu-Ru Lee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Cell Biology

Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

Can-Bin Fang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?

Lamis Yehia et al.

HUMAN MOLECULAR GENETICS (2020)

Review Pharmacology & Pharmacy

Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions

Lloyd D. Fricker et al.

MOLECULAR PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Rbm24 modulates adult skeletal muscle regeneration via regulation of alternative splicing

Mengkai Zhang et al.

THERANOSTICS (2020)

Editorial Material Biochemistry & Molecular Biology

PTEN Mutations Trigger Resistance to Immunotherapy

Feixiong Cheng et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Oncology

Inherited variants in XRCC2 and the risk of breast cancer

Wojciech Kluzniak et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Oncology

Gene expression signature of atypical breast hyperplasia and regulation by SFRP1

Kelly J. Gregory et al.

BREAST CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-lin Huang et al.

Article Biochemistry & Molecular Biology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

Anand Mayakonda et al.

GENOME RESEARCH (2018)

Article Multidisciplinary Sciences

Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes

Luis Zapata et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Antonio Colaprico et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Biochemistry & Molecular Biology

Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk

Jennifer B. Permuth et al.

HUMAN MOLECULAR GENETICS (2016)

Article Biochemistry & Molecular Biology

FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing

Ronglai Shen et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Medicine, General & Internal

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Celine Lefebvre et al.

PLOS MEDICINE (2016)

Article Immunology

PTEN Is a Negative Regulator of NK Cell Cytolytic Function

Edward L. Briercheck et al.

JOURNAL OF IMMUNOLOGY (2015)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Genetics & Heredity

Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer

Jie Sun et al.

PLOS GENETICS (2015)

Article Oncology

Breast Cancer in a RAD51D Mutation Carrier: Case Report and Review of the Literature

Jennifer L. Baker et al.

Clinical Breast Cancer (2014)

Article Biochemical Research Methods

Trimmomatic: a flexible trimmer for Illumina sequence data

Anthony M. Bolger et al.

BIOINFORMATICS (2014)

Article Oncology

DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer

Stephan Woditschka et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Biochemistry & Molecular Biology

svaseq: removing batch effects and other unwanted noise from sequencing data

Jeffrey T. Leek

NUCLEIC ACIDS RESEARCH (2014)

Article Multidisciplinary Sciences

Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis

Bodour Salhia et al.

PLOS ONE (2014)

Article Cell Biology

PTEN Interacts with Histone H1 and Controls Chromatin Condensation

Zhu Hong Chen et al.

CELL REPORTS (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest

Emily A. Nizialek et al.

HUMAN MOLECULAR GENETICS (2013)

Article Genetics & Heredity

Pan-cancer patterns of somatic copy number alteration

Travis I. Zack et al.

NATURE GENETICS (2013)

Editorial Material Genetics & Heredity

The Cancer Genome Atlas Pan-Cancer analysis project

John N. Weinstein et al.

NATURE GENETICS (2013)

Article Oncology

Lifetime Cancer Risks in Individuals with Germline PTEN Mutations

Min-Han Tan et al.

CLINICAL CANCER RESEARCH (2012)

Article Multidisciplinary Sciences

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt et al.

NATURE (2012)

Article Multidisciplinary Sciences

MUC5B Leads to Aggressive Behavior of Breast Cancer MCF7 Cells

Helene Valque et al.

PLOS ONE (2012)

Article Oncology

Identification of a Z-band associated protein complex involving KY, FLNC and IGFN1

Jane Baker et al.

EXPERIMENTAL CELL RESEARCH (2010)

Article Biochemistry & Molecular Biology

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Aaron McKenna et al.

GENOME RESEARCH (2010)

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)

Article Oncology

PRAME expression and clinical outcome of breast cancer

M. T. Epping et al.

BRITISH JOURNAL OF CANCER (2008)

Review Biochemistry & Molecular Biology

Vitamin E, antioxidant and nothing more

Maret G. Traber et al.

FREE RADICAL BIOLOGY AND MEDICINE (2007)

Article Cell Biology

Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues

C Sóñora et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)

Article Biochemistry & Molecular Biology

cDNA cloning and expression of CYP4F12, a novel human cytochrome P450

J Bylund et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)